Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-29T18:30:17.242Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of tianeptine on the hypothalamic control of the corticotropic response to stress

Published online by Cambridge University Press:  16 April 2020

V Guillaume ,
E Magnan ,
M Cataldi ,
F Héry ,
A Dutour ,
F Dadoun ,
L Mazzocchi ,
M Grino ,
B Conte-Devolx  and
C Oliver
...Show all authors
V Guillaume
Affiliation:
Laboratoire de Neuroendocrinologie Expérimentale, INSERM U 297, Faculté de Médecine Nord, boulevard Pierre Dramard, 13326Marseille Cedex 2020
E Magnan
Affiliation:
Laboratoire de Neuroendocrinologie Expérimentale, INSERM U 297, Faculté de Médecine Nord, boulevard Pierre Dramard, 13326Marseille Cedex 2020
M Cataldi*
Affiliation:
Laboratoire de Neuroendocrinologie Expérimentale, INSERM U 297, Faculté de Médecine Nord, boulevard Pierre Dramard, 13326Marseille Cedex 2020
F Héry
Affiliation:
Laboratoire de Neuroendocrinologie Expérimentale, INSERM U 297, Faculté de Médecine Nord, boulevard Pierre Dramard, 13326Marseille Cedex 2020
A Dutour
Affiliation:
Laboratoire de Neuroendocrinologie Expérimentale, INSERM U 297, Faculté de Médecine Nord, boulevard Pierre Dramard, 13326Marseille Cedex 2020
F Dadoun
Affiliation:
Laboratoire de Neuroendocrinologie Expérimentale, INSERM U 297, Faculté de Médecine Nord, boulevard Pierre Dramard, 13326Marseille Cedex 2020
L Mazzocchi
Affiliation:
Laboratoire de Neuroendocrinologie Expérimentale, INSERM U 297, Faculté de Médecine Nord, boulevard Pierre Dramard, 13326Marseille Cedex 2020
M Grino
Affiliation:
Laboratoire de Neuroendocrinologie Expérimentale, INSERM U 297, Faculté de Médecine Nord, boulevard Pierre Dramard, 13326Marseille Cedex 2020
B Conte-Devolx
Affiliation:
Laboratoire de Neuroendocrinologie Expérimentale, INSERM U 297, Faculté de Médecine Nord, boulevard Pierre Dramard, 13326Marseille Cedex 2020
C Oliver*
Affiliation:
Laboratoire de Neuroendocrinologie Expérimentale, INSERM U 297, Faculté de Médecine Nord, boulevard Pierre Dramard, 13326Marseille Cedex 2020
MC Rettori
Affiliation:
Institut de Recherches Internationales Servier, 6, place des Pléiades, 92415Courbevoie Cedex, France
E Mocaër
Affiliation:
Institut de Recherches Internationales Servier, 6, place des Pléiades, 92415Courbevoie Cedex, France
A Kamoun
Affiliation:
Institut de Recherches Internationales Servier, 6, place des Pléiades, 92415Courbevoie Cedex, France
*
*Present address: Istituto di Endocrinologia, IIa Facoltà di Medicina, Via S Pansini n°5, 80131 Naples, Italy.
*Present address: Istituto di Endocrinologia, IIa Facoltà di Medicina, Via S Pansini n°5, 80131 Naples, Italy.
Get access

Summary

Stress-induced stimulation of corticotropic function involves the activation of hypothalamic corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP), which can be measured by improved methods of neuroendocrine investigation. The antiserotoninergic tricyclic antidepressant, tianeptine, reduces the corticotropic response to stress, as shown by a reduction in hypothalamo-hypophyseal portal CRH and AVP levels.

Keywords

stressCRHAVPtianeptine
Type
Research Article
Information
European Psychiatry , Volume 8 , Issue S2: Neuroendocrinological aspects of depression 28 June 1992, Nice, France , 1993 , pp. 55s - 60s
Copyright
Copyright © Elsevier, Paris 1993

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Antoni, FA (1986) Hypothalamic control of adrenocorticotropin secretion: advances since the discovering of 41-residue corticotropin-releasing factor. Endocrinol 7, 351–373Google Scholar
Barbanel, GIxart, GAssenmacher, I (1991) In vivo infusion of adrenaline stimulates corticotropin-releasing hormone producing neurons when given centrally but not distally. J Neuroendocrinol 3, 145–148CrossRefGoogle Scholar
Bess, JCBass, AD (1966) Potentiation by hydrocortisone of responses to catecholamine in vascular smooth muscle. J Pharmacol Exp Ther 154, 224–238Google Scholar
Caraty, AGrino, MLocatelli, AOliver, C (1988) Secretion of corticotropin releasing factor (CRF) and vasopressin (AVP) into the hypophyseal portal blood of conscious, unrestrained rams. Biochem Biophys Res Commun 155,841–849CrossRefGoogle ScholarPubMed
Delbende, CContesse, VMocaër, EKamoun, AVaudry, H (1991) The novel antidepressant tianeptine reduces stress-evoked stimulation of the hypothalamo-pituitaryadrenal axis. Eur J Pharmacol 202, 391–396CrossRefGoogle Scholar
Delbende, CDelarue, CLefebvre, HTranchand, BDSzafarczyk, AMocaër, EKamoun, AJégou, SVaudry, H (1992) Glucocorticoids, transmitters and stress. Br J Psychiatr 160 (suppl 15), 25–34CrossRefGoogle Scholar
Fattacini, CMBolanos-Jimenez, FGozlan, HHamon, M (1990) Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain. Neuropharmacology 29, 1–8CrossRefGoogle Scholar
Feldman, SMelamed, EConforti, NWeidenfeld, J (1984) Effect of central serotonin depletion on adrenocortical responses to neural stimuli. Exp Neurol 85, 661–666CrossRefGoogle ScholarPubMed
Conte-Devolx, BRey, MBoudouresque, FGiraud, PCastanas, EMillet, YCodaccioni, JLOliver, C (1982) Effet de l'immunisation passive avec un sérum anti-CRF sur la secrétion d'ACTH du rat. CR Acad Sci D (Paris) 285, 647–650Google Scholar
Feldman, SConforti, NMelamed, E (1989) Paraventricular nucleus serotonin mediates neurally stimulated adrenocortical secretion. Brain Res 496, 219–227Google Scholar
Gibbs, DMVale, W (1983) Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophyseal portal blood. Brain Res 280, 176–179CrossRefGoogle Scholar
Guillaume, VConte-Devolx, BMagnan, EBoudouresque, FGrino, MCataldi, MMuret, LPriou, ADeprez, PFigaroli, JCOliver, C (1992) Effect of chronic active immunization with anti-corticotropin-releasing factor on the pituitary-adrenal function in the sheep. Endocrinology 130, 2291–2298Google ScholarPubMed
Guillaume, VConte-Devolx, BSzafarczyk, AMalaval, FPares-Herbute, NGrino, MAlonso, GAssenmacher, IOliver, C (1987a) The corticotropin-releasing factor release in rat hypophyseal portal blood is mediated by brain catecholamines. Neuroendocrinology 46, 143–146CrossRefGoogle Scholar
Guillaume, VPeyre, GDutour, AOuafik, L'HConte- Devolx, BOliver, C (1987b) Méthodes de collection du sang porte hypothalamo-hypophysaire. Ann Endocrinol (Paris) 48, 407–409Google Scholar
Holmes, MCDi Renzo, GBeckford, UGillham, BJones, MT (1982) Role of serotonin in the control of secretion of corticotrophin releasing factor. J Endocrinol 93,151–160CrossRefGoogle ScholarPubMed
King, MSBaertschi, AJ (1990) The role of intracellular messengers in adrenocorticotropin secretion in vitro. Experientia 46, 26–40CrossRefGoogle Scholar
Kiss, JZ (1988) Dynamism of chemoarchitecture in the hypothalamic paraventricular nucleus. Brain Res Bull 20, 699–708CrossRefGoogle ScholarPubMed
Liposits, ZSPhelix, CPaull, WK (1987) Synaptic interaction of serotonergic axons and corticotropin-releasing factor (CRF) synthesizing neurons in the hyposthalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study. Histochemistry 86, 541–549CrossRefGoogle Scholar
McEwen, BS (1991) Stress et hippocampe. Le point sur les connaissances actuelles. Presse Méd 20, 1801–1806Google Scholar
McEwen, BSGould, EASakai, RR (1992) The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress. Br J Psychiatr 160 (suppl 15), 18–23CrossRefGoogle Scholar
Mocaër, ERettori, MCKamoun, A (1988) Pharmacological antidepressive effects and tianeptine-induced 5-HT uptake increase. Clin Neuropharmacol 11, S32–S42Google ScholarPubMed
Munck, AGuyre, PHolbrook, N (1984) Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrinol Rev 5, 25–44CrossRefGoogle ScholarPubMed
Oliver, CJezova, DGrino, MGuillaume, VBoudouresque, FConte-Devolx, BPesce, GDutour, ABecquet, D (1990) Differences in the effects of acute and chronic administration of dexfenfluramine on Cortisol and prolactin secretion.In: Circulatory Regulatory Factors and Neuroendocrine Function (Porter, JCJezova, D eds). New York, Plenum Press, pp. 427–443CrossRefGoogle Scholar
Ono, NDe Castro, JBKhorram, OMcCann, SM (1985) Role of arginine vasopressin in control of ACTH and LH release during stress. Life Sci 36, 1779–1786CrossRefGoogle ScholarPubMed
Plotsky, PMCunningham, ETWidmaier, EP (1989) Catecholarninergic modulation of corticotropin-releasing factor and adrenocorticotropin secretion. Endocrinol Rev 10,437–458CrossRefGoogle ScholarPubMed
Sapolsky, R (1986) Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels. J Neurosci 6, 2240–2244CrossRefGoogle ScholarPubMed
Selye, H (1946) The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinol Metab 6, 117–230CrossRefGoogle ScholarPubMed
Szafarczyk, AAlonso, GIxart, GMalaval, FAssenmacher, I (1985) Diurnal-stimulated and stress-induced ACTH release in rats is mediated by ventral noradrenergic bundle. Am J Physiol 249, E219–E226Google ScholarPubMed
Uno, HRoss, TElse, JSuleman, MSapolsky, R (1989) Hippocampal damage associated with prolonged and fatal stress in primates. J Neurosci 9, 1705–1711CrossRefGoogle ScholarPubMed
Whitnall, MH (1989) Stress selectively activates the vasopressin-containing subset of corticotropin-releasing hormone neurons. Neuroendocrinology 50, 702–707CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.